bigwhalealert Posted - 2 years ago

$PRAH BUY/SELL METER Alert Cross 18% + 🚀 https://t8sk.com/PRAH

Aldoxorubicinwins Posted - 02/23/22

@drizz the value is in the patent @drizz ya gotta understand the FDA gave $CYTR Extended Dosing in 2014 and $PRAH health science won the Gold Award for data retrieval with Aldoxorubicin so $IBRX s Soon Shoing has his name on multiple patents and ya gotta understand $BMY originally owned Aldoxorubicin and sold it to KTB who sold it to Innovive and they want it back, just look at the patent Dosing amounts with no cardiotoxic SAEs

Aldoxorubicinwins Posted - 2 years ago

$CYTR $IBRX if these numbers are true - Aldoxorubicin will be approved as the 1st Anthracycline to cross the blood brain barrier. patents.google.com/patent/W... With FDA approval for Extended Dosing in 2014 - these numbers were documented and recorded by $PRAH PRA Health Sciences who received the Gold Award recording in detail Aldoxorubicin doses throughout the clinical trial at numerous sites. Apr 25, 2016 — CytRx And PRA Health Sciences Receive Gold Awards For Excellence In Clinical Research As The Strategic Partnership Team Of The Year 17. The method of any one of claims 13-14 wherein the doxorubicin cumulative dose is at least 10,000 mg/m2 18. The method of any one of claims 13-14 wherein the doxorubicin cumulative dose does not produce cardiotoxicity. 19. A method of reducing alopecia induction

bigwhalealert Posted - 2 years ago

$PRAH TA Stats Today's Change 33% + 🚀 https://t8sk.com/PRAH

bigwhalealert Posted - 2 years ago

$PRAH Tweets Stats Today's Change 33% + 🚀 https://t8sk.com/PRAH

cctranscripts Posted - 2 years ago

Massachusetts Financial Services Company just issued a filing suggesting it has sold all of its https://www.conferencecalltranscripts.com/summary/?id=10386646 $PRAH

fla Posted - 2 years ago

$PRAH [15s. delayed] filed form SC 13G/A on February 02, 12:46:55 https://s.flashalert.me/BYbNK

Newsfilter Posted - 01/25/22

$PRAH Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation - NCT05205863 https://newsfilter.io/a/8da5f9dfc05c35e2850972e2bc55fa36

Aldoxorubicinwins Posted - 2 years ago

@dannymac65 they can actually lol, but that's for another day, don't ask me about $PRAH Health Sciences getting the Gold Award for $CYTR 's Aldoxorubicin clinical trial, don't. lol, but they can manipulate data and they do, and they remove "end points" like they did with $ORPH and do not ask about Biogen's Aduhelm approval. Don't get me wrong - I am all for approval of Aldoxorubicin + Cher's Drug - VesAnktiva

Im_not_Mr_Lebowski Posted - 2 years ago

$MEDP I will 100% be investing in this after the downfall. I think there's a very real chance this is acquired by $ICLR or $IQV in the not too distant future. But even if independent...what a tremendous job they've done. Like $PRAH but way better.

bigwhalealert Posted - 2 years ago

$PRAH Twits Stats Today's Change 33% + 🚀 https://t8sk.com/PRAH

bigwhalealert Posted - 11/25/21

$PRAH Twits Stats Today's Change 33% + 🚀 https://t8sk.com/PRAH

macroaxis Posted - 3 years ago

$PRAH - Option Volatility signal: PRA Health pin risk is dropping https://www.macroaxis.com/stock-options/PRAH/PRA-Health-Sciences?utm_source=dlvr.it&utm_medium=stocktwits

bigwhalealert Posted - 10/26/21

$PRAH Tweet Stats Today's Change 30% + 🚀 https://t8sk.com/PRAH

bigwhalealert Posted - 3 years ago

$PRAH Tweet Stats Today's Change 30% 🚀 + https://t8sk.com/PRAH

bigwhalealert Posted - 3 years ago

$PRAH Tweet Stats Today's Change 30% 🚀 + https://t8sk.com/PRAH

bigwhalealert Posted - 3 years ago

$PRAH Tweet Stats Today's Change 30% 🚀 + https://t8sk.com/PRAH

bigwhalealert Posted - 3 years ago

$PRAH Tweet Stats Today's Change 30% + https://t8sk.com/PRAH

Newsfilter Posted - 3 years ago

$PRAH A Phase 1b, Randomized, 2-Part Evaluation of Oral PF614 Relative to OxyContin - NCT05043766 https://newsfilter.io/a/ce75314c41f5d3c5c9e939ec3cdf7d78

Aldoxorubicinwins Posted - 3 years ago

@cosmic0ne the real question is - Did Patrick Soon Shiong pay off John Caloz - the master mind who dropped $CYTR stock to the OTC after "due diligence" (due diligence meaning if Soon Shiong slips chunks of moolah into a private bank account - makes sense to just hide $CYTR on the OTC, no different than Altor Biosciences, which is why they sued Soon Shiong, then Cher sued Soon Shiong, then Dr. Henry Li Sued Soon Shiong) the only ones who have not sued Soon Shiong for fraudulent concealment or Catch n Kill - is: ? yep, you have it - $CYTR shareholders are getting the old Soon Shiong fisting up the old colon and the explanation is Aldoxorubicin failed phase III trials, based on a compassionate use death which skewed statistical significance because there was a break in the continuity of the data set. $PRAH Health Sciences still won the Gold Award for their recorded data - at Mass General Hospital no less. Did Soon Shiong pay off John Caloz to drop $CYTR to the OTC?

InsiderForms Posted - 3 years ago

Twin Securities Inc.,has filed Form 13F for Q2 2021.Opened NEW positions in $ACRS $MXIM $PFPT $PRAH $WBT

Aldoxorubicinwins Posted - 3 years ago

@bike_it_59 Based on the S-4 filed in January 2021 they were in talks with the FDA using the Aldoxorubicin data from $CYTR's prior clinical trials. Understand, as I know you do, but for Others here - $PRAH won the Gold Award for documenting the clinical data from multiple sites globally including Mass General Hospital in Boston. The data is valaid. The FDA gave Extended Dosing in 2014. This alone has proven fruitful to substantiate that Aldoxorubicin works, Aldoxorubicin is safer, Aldoxorubicin is less cardio toxic because it binds to Albumin with the Hydrazone linker. Dr. Patrick Soon Shiong's delay in filing the NDA for Aldoxorubicin is based on the Celgene non compete w Abraxane and we know how hard $BMY Bristol Myers fought to keep generic Abraxane away from patients. The system is rigged, and motivated by Sales figures. Whether Soon is "secretly" running trials elsewhere I don't know - but his name is planted on multiple Aldoxorubicin patents for reward.

InsiderForms Posted - 3 years ago

TradeLink Capital LLC,has filed Form 13F for Q2 2021.Opened NEW positions in $PRAH

ChartMill Posted - 07/24/21

Measured over the past 5 years, $PRAH shows a quite strong growth in Revenue: 14.55% on average per year. https://www.chartmill.com/stock/analyzer/stock/PRAH?view=fundamental-analysis&key=3dc36b89-3895-4eec-a467-65425bdeaffa&utm_source=stocktwits&utm_medium=FA&utm_content=PRAH&utm_campaign=social_tracking

Newsfilter Posted - 07/23/21

$RDUS $PRAH RWE Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women - NCT04974723 https://newsfilter.io/a/55d3aef9d78d6f81a1ec2982dc0b860c

cctranscripts Posted - 3 years ago

Securities registration termination [Section 12(b)] https://www.conferencecalltranscripts.com/summary/?id=9641465 $PRAH

risenhoover Posted - 3 years ago

$PRAH / PRA Health Sciences files form 15-12B https://fintel.io/sf/us/prah?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Newsfilter Posted - 3 years ago

$PRAH Form 15-12B (securities registration termination [section 12(b)]) filed with the SEC https://newsfilter.io/a/8fc290063e0239fd444f1439afc88a47

cctranscripts Posted - 3 years ago

Israel A. Englander just issued a filing suggesting it has sold all of its PRA Health Sciences, https://www.conferencecalltranscripts.com/summary/?id=9638348 $PRAH

Quantisnow Posted - 3 years ago

$PRAH 📜 SEC Form SC 13G filed by PRA Health Sciences, Inc. https://quantisnow.com/insight/1334556?s=s